{
    "Trade/Device Name(s)": [
        "TearLab Osmolarity System"
    ],
    "Submitter Information": "OcuSense, Inc.",
    "510(k) Number": "K083184",
    "Predicate Device Reference 510(k) Number(s)": [
        "K991316",
        "K971976"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "OND",
        "JJX"
    ],
    "Summary Letter Date": "June 2, 2009",
    "Summary Letter Received Date": "April 23, 2009",
    "Submission Date": "April 23, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.1540"
    ],
    "Regulation Name(s)": [
        "Osmolality test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Osmolarity"
    ],
    "Specimen Type(s)": [
        "Tears"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "TearLab Reader",
        "TearLab Pen"
    ],
    "Method(s)/Technology(ies)": [
        "Electrical impedance measurement"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Test Card",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for TearLab Osmolarity System for measuring tear osmolarity to aid diagnosis of dry eye disease",
    "Indications for Use Summary": "Intended to measure osmolarity of human tears to aid in the diagnosis of dry eye disease in patients suspected of having dry eye disease, used in conjunction with other clinical evaluation methods",
    "fda_folder": "Clinical Chemistry"
}